Group Companies

PHC Corporation

PHC Corporation

Core Businesses: Diabetes and Other Diagnostics, Life Sciences and Healthcare IT

PHC Corporation is a Japan-based subsidiary of PHC Holdings Corporation. The company develops, manufactures, sells and services medical equipment and solutions across diabetes and other diagnostics, life sciences and healthcare IT.

Business Brands

PHCbi

PHCbi is a brand that has supported cutting-edge research and healthcare through their global sales and services network for over 50 years.

Medicom

The Medicom (medical information systems) Division makes efforts to improve healthcare solutions for patients and work efficiency for healthcare professionals by utilizing its accumulated experience and knowledge, and its service support capability.

Ascensia Diabetes Care Holdings AG

Ascensia Diabetes Care Holdings AG

Core Businesses: Diabetes Management

Ascensia is a wholly owned subsidiary of PHCHD specializing in global diabetes management business. The company sells blood glucose monitoring systems and related applications in more than 125 countries.

Product brand:

CONTOUR®

Through blood glucose monitoring systems using highly precise measuring technologies, and data linkage solutions utilizing IoT technology, we will contribute to the treatment and QOL improvement for diabetes patients.

Epredia

epredia

Core Businesses: Diagnostics

Epredia is a global company engaged in development, manufacturing and sales of comprehensive anatomical pathology solutions. The company became a member of PHC Group in June 2019 and takes pride in its wide range of product lineups such as anatomical pathology instruments, microscope slides, and dyeing reagents.

LSI Medience Corporation

epredia

Core Businesses: Healthcare Solutions

Japan's leading healthcare solutions company with three core businesses: clinical testing, IVD products, and drug development support services in Japan. LSI Medience became a member of PHC Group in August 2019, contributing to the prevention, early detection and treatment of illness.

Newsroom